Call for Abstract

International Conference on Flu, will be organized around the theme “Advanced Research in Flu ”

Flu-2015 is comprised of 11 tracks and 52 sessions designed to offer comprehensive sessions that address current issues in Flu-2015.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Adjuvants
  • Track 1-2Preservatives
  • Track 1-3Side-effects of vaccines on infants, children, pregnant women and elderly patients
  • Track 1-4Deciding predominant strains
  • Track 1-5Effectiveness of multivalent vaccines
  • Track 1-6Effective choice of strains to include in multivalent vaccines
  • Track 2-1Flu and their case reports
  • Track 2-2New strategies to combat flu viruses
  • Track 2-3Stem cell therapy for viral infections
  • Track 2-4Clinical virology
  • Track 2-5Strain identification assays and rapid diagnostic testing for viral infections
  • Track 2-6Containment of flu outbreaks
  • Track 3-1System virology and its contribution to drug targeting
  • Track 3-2Genomics and role in drug design
  • Track 3-3Lead targets in drug discovery
  • Track 3-4Bioinformatics in drug discovery
  • Track 3-5Effects of steroids on Influenza virus
  • Track 4-1Role of enzymes and infection mechanisms
  • Track 4-2Genetic analysis of influenza virus
  • Track 4-3Immune responses to influenza infections
  • Track 4-4T cells and their role in influenza infections
  • Track 4-5Innate immunity mechanisms
  • Track 4-6Aging and influenza infections
  • Track 5-1Mutation rates and factors
  • Track 5-2Effectiveness of current anti-virals
  • Track 5-3Phylogenetic analysis of influenza strains
  • Track 5-4Effects of allele change on virulence
  • Track 5-5Risk of a superbug
  • Track 6-1Human- animal interactions
  • Track 6-2Prediction of zoonoses
  • Track 6-3Analysis of new strains evolved by zoonoses
  • Track 6-4Ebola
  • Track 6-5Swine flu
  • Track 7-1Assays and symptoms
  • Track 7-2Rapid detection methods by PCR
  • Track 7-3Nanotechnology and strain differentiation
  • Track 8-1Interaction between Influenza and Pneumococci
  • Track 8-2Co-pathogenesis
  • Track 8-3Multi-host and multi-pathogen/parasite systems
  • Track 8-4Antimicrobial defense and influenza infection
  • Track 9-1Current antivirals and side-effects
  • Track 9-2Resistance to current antivirals
  • Track 9-3Supply of antivirals
  • Track 9-4Antiviral drug resistance
  • Track 9-5Antiviral drugs and adjuvants
  • Track 10-1 Efficacy of Chinese traditional medicine on influenza
  • Track 11-1DNA vaccines
  • Track 11-2Interleukin immune therapy
  • Track 11-3Antibody therapy against viruses
  • Track 11-4Gene therapy for viral infections
  • Track 11-5Viral vaccines and safety evolution
  • Track 11-6Antigen presenting cell-targeted therapy